Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome.

Beumer, Jan H

Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome. [electronic resource] - Pharmacotherapy Jul 2006 - 903-7 p. digital

Publication Type: Case Reports; Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0277-0008

10.1592/phco.26.7.903 doi


Antineoplastic Agents--blood
Benzamides
Female
Humans
Imatinib Mesylate
Jejunostomy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Middle Aged
Piperazines--blood
Pyrimidines--blood
Short Bowel Syndrome--metabolism